Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

The pharmaceutical company is running investigational new drug experiments, studies required by the FDA to demonstrate the ...

IonQ , the world's leading quantum company, and SkyWater Technology , the largest exclusively U.S.-based, pure-play semiconductor foundry, today announced they have entered into a definitive agreement ...

Amid the industry's rapid transition from AI experimentation to scaled execution, the Interactive Advertising Bureau (IAB), the leading trade association for the digital advertising ecosystem, today ...

You get smart. Then you get uncomfortably smart. That rare, off-the-charts, stop-everyone-in-their-tracks type of ...

Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

Viruses attack nearly every living organism on Earth. To do so, they rely on highly specialized proteins that recognize and ...

Nivalon Medical Technologies Inc. has successfully produced the world's first fully patient-specific, motion-preserving spinal implant built entirely without metal, using AI-driven design and advanced ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...